8 Jun 2021

Updated 2 Nov 2021

Discrete Choice Experiment: How to Run a Preference Study with the DCE Methodology


Discrete Choice Experiment: How to Run a Preference Study with the DCE Methodology

Are you interested in Preference studies? You have heard about DCE, but not sure whether this approach is the most appropriate for you? You want to know how to define such a project and understand outcomes you would expect from?

We are happy to announce our upcoming webinar at XTalks on Friday, June 25, 2021, 9am EDT (NA) / 2pm BST (UK) / 3pm CEST (EU-Central):

During this webinar, we will share Carenity’s expertise in leading preference studies using DCE and you’ll have the opportunity to hear about one of their customer experiences.

Carenity, part of EvidentIQ, is a leading digital social platform supporting 500k patients and caregivers worldwide across 1,000+ illnesses. Carenity’s mission is to empower patients so they can share their experience with other patients living with the same conditions, find information, manage their illness, and advance medical knowledge by participating in online research studies. With its innovative platform, Carenity delivers timely and compliant direct-to-patient research solutions to the life sciences industry that fuel the development of better medicines and services.

With Takeda, an patient-focused and R&D-driven global biopharmaceutical company and long-term partner of Carenity, we will talk about the importance and benefits of a DCE preference study and how we combined our respective skills.

Among the different approaches possible, the Discrete Choice Experiment is now recognized as a gold standard and yet, few projects using this methodology have been shared. A Preference study is a must have for any patient-centric organization when decisions have to be made to drive a product development and ensure it meets patients’ expectations.

Register now for free to hear our experts defining Discrete Choice Experiment (DCE) and sharing their experiences in leading preference studies using DCE

What you will learn in this webinar:

  • The definition of DCE
  • What is the value of DCE
  • Best practices implementation
  • How to build a preference study using DCE

    Our Speakers are:

Lise Radoszycki Chief Operating Officer at Carenity

Nawal Bent-Ennakhil Lead Epidemiologist at Takeda

Nawal Bent-Ennakhi

The DCE methodology is a gold standard approach in preference studies and Lise will share with you some guidelines and tips learnt throughout Carenity’s experience. Nawal will explain how Takeda built a preference study along with Carenity and how this project helped to uncover patients’ preferences in real life.

Read the full abstract and book your spot by registering. We hope you and your colleagues will join us!

EvidentIQ is a next generation technology-amplified data science group championing new standards in value creation and innovation driven relevance for customers. The EvidentIQ offering brings a pioneering end to end eClinical solution that meets increasing customer demand across clinical operations and clinical data management needs with a suite of applications within a single integrated cloud platform. By combining its platform with a broad data science service portfolio such as patient recruitment, patient engagement media and a host of RWE late phase solutions EvidentIQ significantly helps customers optimize HTA submissions, pricing and reimbursement needs.

EvidentIQ supports 15 of the top 20 pharma companies through novel RWE solutions and 150+ SMB customers in over 20 countries, including US, Germany, France, UK, Italy, Japan and China.

Contact us for more information: 

Image Credit:Foto von Karolina Grabowska von Pexels

Get a Demo

Let us show you how we can help you.

Get a Quote

Discover a solution tailored to your needs and budget.

Get a Meeting

Let’s start a new project together!

Let’s Start
a conversation

Ready to discover how our platform and its suite of applications can meet your needs?


    We use cookies to personalize content and ads, provide social media features, and analyze traffic to our website. Our partners may combine this information with other data they have provided to you or collected from your use of the services. Because we value your privacy, we hereby request your permission to use the following technologies. You may change / revoke your consent later at any time by clicking on the settings in the lower left corner of the page.

    Please note that according to a recent ruling by the European Court of Justice (ECJ), there is no adequate level of data protection in the USA and therefore a risk to the protection of your data. For example, under certain conditions, your data may be processed by US authorities for control and monitoring purposes. In addition, we currently refer to Art. 49 GDPR with regard to the legal basis for the transfer of data. After implementation of the new EU standard data protection clauses, these will constitute the legal basis for data transfer to third countries.